SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the potential for a transformative buyout following reports of massive pharmaceutical M&A activity in the oncology space. Community discussions are highly polarized, with bulls highlighting the trial's prolonged survival timeline as evidence of therapeutic success, while bears express concern over the company's financial structure and the potential for a binary clinical outcome.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant community attention as investors position for imminent long-term efficacy results from the VELA Phase 3 program, which many view as a critical rerating catalyst. With institutional interest rising and active discussions focused on the potential for superior clinical data compared to current market leaders, participants are closely monitoring the upcoming investor conference for possible M&A discussions or pipeline updates.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is witnessing extreme volatility and a parabolic rally, fueled by intense investor enthusiasm surrounding AI-driven memory storage demands and persistent supply chain bottlenecks. The stock has become a primary focal point for momentum traders, sparking heated debates between bulls banking on a structural supercycle and bears warning of a speculative bubble due to its rapid, historic price appreciation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending as traders closely monitor escalating geopolitical tensions in the Strait of Hormuz and the status of US-Iran negotiations, which remain a primary driver of market sentiment. The community is actively debating the sustainability of the current AI-led market rally, with many investors weighing the risks of high capital expenditures against potential economic instability and rising interest rates.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant momentum and record highs driven by a widely reported partnership with Apple for domestic chip manufacturing, a development that has reinvigorated the bull case for the company's foundry turnaround. The community remains deeply divided, with bulls pointing to heavy institutional volume and long-term infrastructure demand, while bears express skepticism over the lack of official corporate confirmation and concerns regarding valuation relative to historical earnings.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing strong investor engagement driven by its structural positioning in the AI data center market and excitement surrounding upcoming product catalysts. The community is actively discussing the stock's role in the broader semiconductor sector rotation, focusing on its ability to capture long-term demand for compute power amidst shifting macroeconomic conditions.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending as investors react to a significant partnership with Midjourney to integrate its ultrasound-on-chip technology into a new AI-powered full-body scanner. While the community is actively debating the stock's long-term potential as a semiconductor play versus immediate dilution risks and a 'sell-the-news' pullback, the stock has seen heightened volume and volatility as bulls look for a breakthrough of key resistance levels.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as the community scrutinizes the company's shift toward high-volume commercial scaling and its strategic expansion into smart glasses, drones, and wearable markets. Investors are actively debating the viability of the company's manufacturing throughput and the recent shift in battery qualification timelines, while monitoring the broader implications of its expanding supply chain partnerships across Asia.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is seeing significant market interest as investors pivot toward its long-term potential in edge AI, automotive, and data center infrastructure, moving beyond its traditional smartphone focus. The community is actively discussing upcoming catalysts like investor day, potential hyperscaler partnerships, and the stock's relative value compared to other high-flying semiconductor peers.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense investor attention following a significant clinical data release for Lupkynis and increased share accumulation by CEO Kevin Tang. While the community is actively debating the potential for an imminent buyout or strategic acquisition, sentiment remains divided between hopeful longs anticipating a catalyst-driven surge and skeptics frustrated by a lack of direct management communication.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Commercial Bancgroup (NASDAQ:CBK) EVP Acquires 3,300 Shares of Stock

Commercial Bancgroup, Inc. (NASDAQ:CBK - Get Free Report) EVP Philip Metheny acquired 3,300 shares of the company's stock in a transaction on Thursday, April 30th. The stock was acquired at an...

Commercial Bancgroup, Inc. (NASDAQ:CBK) to Issue $0.10 Quarterly Dividend

Commercial Bancgroup, Inc. (NASDAQ:CBK) announced a quarterly dividend on Monday, April 27th. Investors of record on Monday, June 15th will be given a dividend of 0.10 per share on Tuesday, June...

Commercial Bancgroup (NASDAQ:CBK) Releases Quarterly Earnings Results

Commercial Bancgroup (NASDAQ:CBK - Get Free Report) issued its quarterly earnings results on Monday. The company reported $999.00 earnings per share (EPS) for the quarter...

Polaris Capital Management LLC Takes Position in Commercial Bancgroup, Inc. $CBK

Polaris Capital Management LLC purchased a new stake in Commercial Bancgroup, Inc. (NASDAQ:CBK - Free Report) during the 4th quarter, according to the company in its most recent filing with the...

62,500 Shares in Commercial Bancgroup, Inc. $CBK Purchased by Rosenthal Henry Capital Advisors Inc.

Rosenthal Henry Capital Advisors Inc. purchased a new position in Commercial Bancgroup, Inc. (NASDAQ:CBK - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 62,500 shares of the company's stock, valued at approx...

Phocas Financial Corp. Acquires Shares of 146,869 Commercial Bancgroup, Inc. $CBK

Phocas Financial Corp. acquired a new stake in shares of Commercial Bancgroup, Inc. (NASDAQ:CBK - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 146,869 shares of the company's stock, valu...

Phocas Financial Corp. Makes New Investment in Commercial Bancgroup, Inc. $CBK

Phocas Financial Corp. bought a new stake in Commercial Bancgroup, Inc. (NASDAQ:CBK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 146,869 shares of the company's stock, valued at app...

Community Trust & Investment Co. Makes New $9.16 Million Investment in Commercial Bancgroup, Inc. $CBK

Community Trust & Investment Co. purchased a new stake in shares of Commercial Bancgroup, Inc. (NASDAQ:CBK - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 373,000 shares of the company's stock, valued at...

Commercial Bancgroup, Inc.'s (NASDAQ:CBK) Lock-Up Period To End on March 31st

Commercial Bancgroup's (NASDAQ:CBK - Get Free Report) lock-up period will end on Tuesday, March 31st. Commercial Bancgroup had issued 7,173,092 shares in its IPO on October 2nd. The total size of the...

Commercial Bancgroup, Inc. (NASDAQ:CBK) Declares Quarterly Dividend of $0.10

Commercial Bancgroup, Inc. (NASDAQ:CBK) declared a quarterly dividend on Monday, January 26th. Stockholders of record on Sunday, March 15th will be paid a dividend of 0.10 per share on Tuesday, March...

Christopher & Banks Corp. engages in the provision of its retail stores, outlet stores, online purchases, and mobile application for women's apparel and accessories. It offers tops, dresses, skirts, jewelry, scarves and wraps, denim, and other collections. The company was founded by Gil Braun in 1956 and is headquartered in Plymouth, MN.

Christopher & Banks Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0001
Prev Close	$0.0001
Open	$0.0001
Dividend Yield	N/A
50-Day Moving Average	$0.00
Beta	0.00
Avg. Volume	152.70
PE Ratio	N/A

52-Week High	$0.0001
52-Week Low	$0.00
Market Capitalization	$3,855.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

CBKChristopher & Banks Corporation

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest CBK News